Modern approaches to the management of recurrent urinary tract infections in women

Cover Page


Cite item

Full Text

Abstract

In the recent years, relapses of infectious and inflammatory diseases of the urinary tract (UTI) have become more common. Doctors in many specialties face the problem of recurrent UTIs. The effectiveness of antibiotics is worsening, while antibiotic resistance is increasing. This review article deals with prevention and treatment of patients with recurrent UTIs. Risk factors for recurrent UTIs are reviewed separately for women in their pre- and post-menopausal age. Based on the literature and our own experience, we discuss therapeutic and preventive measures for these disorders. Today, preventive measures for recurrent UTIs involve not only lifestyle modification, herbal treatments and improvement of immune response, but also vaginal estrogen replacement therapy in postmenopausal women, immune prophylaxis, normalization of urinary output, water-induced diuresis, urine acidification, vaginal application of the lactobacilli, long-term low-dose and/or postcoital drug prophylaxis in various combinations. It is emphasized, that current guidelines on the prevention of recurrent UTIs are primarily focused on non-antibiotic measures. However, the necessary prerequisite or initiation of any prevention regimen is a negative urine culture after the eradication of the pathogen. A list of the most common herbal preparations is included into the review. Immunoactive prophylaxis and stimulation of an individual immune response is considered to be a  new strategy in the management of patients with recurrent UTIs. Characteristics of antibacterials are given from the evidence-based perspective. Individual and sexual hygiene are both important conditions for the successful prevention of UTI relapses and successful treatment of recurrent UTIs.

About the authors

B. A. Rebrov

Lugansk State Medical University St. Luke

Author for correspondence.
Email: fpdo@mail.ru
MD, PhD, Professor, Head of the Chair of Internal Medicine, Postgraduate Faculty Russian Federation

References

  1. Naber KG, Bergman B, Bishop MC, Bjerklund-Johansen TE, Botto H, Lobel B, Jinenez Cruz F, Selvaggi FP; Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU). EAU guidelines for the management of urinary and male genital tract infections. Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU). Eur Urol. 2001;40(5): 576–88.
  2. Зайцев АВ, Касян ГР, Спивак ЛГ. Цистит. Урология. 2016;(3 Прилож):18–27.
  3. Grabe M, Bartoletti R, Bjerklund Johansen TE, Cai T, Çek M, Köves B, Naber KG, Pickard RS, Tenke P, Wagenlehner F, Wullt B. Guidelines on urological infections [Internet]. European Association of Urology; 2015 [cited 2017 Nov 23]. 86 p. Доступно на: https://uroweb.org/wp-content/ uploads/19-Urological-infections_LR2.pdf.
  4. Terlizzi ME, Gribaudo G, Maffei ME. UroPathogenic Escherichia coli (UPEC) Infections: Virulence Factors, Bladder Responses, Antibiotic, and Non-antibiotic Antimicrobial Strategies. Front Microbiol. 2017;8:1566. doi: 10.3389/ fmicb.2017.01566.
  5. Дядык АИ, Колесник НА. Инфекции почек и мочевыводящих путей. Донецьк: Регіон; 2003. 400 с.
  6. Colgan R, Nicolle LE, McGlone A, Hooton TM. Asymptomatic bacteriuria in adults. Am Fam Physician. 2006;74(6): 985–90.
  7. Cai T, Verze P, Brugnolli A, Tiscione D, Luciani LG, Eccher C, Lanzafame P, Malossini G, Wagenlehner FM, Mirone V, Bjerklund Johansen TE, Pickard R, Bartoletti R. Adherence to European Association of Urology Guidelines on Prophylactic Antibiotics: an important step in antimicrobial stewardship. Eur Urol. 2016;69(2): 276–83. doi: 10.1016/j.eururo.2015.05.010.
  8. Пасєчніков СП. Цистит: етіопатогенез, класифікація, клінічна картина, діагностика, лікування. Український медичний часопис. 2016;(4): 34–6.
  9. Bjerklund Johansen TE, Bonkat G, Cai T, Tandogdu Z, Wagenlehner F, Grabe M. Grey zones in the field of urinary tract infections. Eur Urol Focus. 2016;2(4): 460–2. doi: 10.1016/j. euf.2016.03.012.
  10. Grabe M, Bishop MC, Bjerklund-Johansen TE, Botto H, Çek M, Lobel B, Naber KG, Palou J, Tenke P, Wagenlehner F. Guidelines on Urological Infections [Internet]. European Association of Urology; 2009 [cited 2017 Nov 23]. 110 p. Доступно на: http://uroweb.org/wp-content/ uploads/EAU-Guidelines-Urological-Infections-2009.pdf.
  11. Korth J, Kukalla J, Rath PM, Dolff S, Krull M, Guberina H, Bienholz A, Wilde B, Becker S, Ross B, Anastasiou OE, Kribben A, Witzke O. Increased resistance of gram-negative urinary pathogens after kidney transplantation. BMC Nephrol. 2017;18(1): 164. doi: 10.1186/s12882-017-0580-z.
  12. Bartoletti R, Cai T, Wagenlehner FM, Naber K, Bjerklund Johansen TE. Treatment of urinary tract infections and antibiotic stewardship. European Urology Supplements. 2016;15(4): 81–7. doi: 10.1016/j.eursup.2016.04.003.
  13. İdil N, Candan ED, Yousefi Rad A, Aksöz N. High trimethoprim-sulfamethoxazole resistance in ciprofloxacin-resistant Escherichia coli strains isolated from urinary tract infection. Minerva Biotec. 2016;28(3): 159–63.
  14. Habibi A, Khameneie MK. Antibiotic resistance properties of uropathogenic Escherichia coli isolated from pregnant women with history of recurrent urinary tract infections. Trop J Pharm Res. 2016;15(8): 1745–50. doi: 10.4314/tjpr. v15i8.21.
  15. Перепанова ТС, Козлов РС, Руднов ВА, Синякова ЛА, Винаров АЗ, Дутов ВВ, Зайцев АВ, Павлов АЮ, Авдошин ВП. Антимикробная терапия и профилактика инфекций почек, мочевыводящих путей и мужских половых органов. Российские национальные рекомендации. М.; 2014.
  16. Pickard R, Bartoletti R, Bjerklund-Johansen TE, Bonkat G, Bruyère F, Çek M, Grabe M, Tenke P, Wagenlehner F, Wullt B, Cai T, Köves B, Pilatz A, Pradere B, Veeratterapillay R. Guidelines on urological infections [Internet]. Euro-pean Association of Urology: 2016 [cited 2017 Nov 23]. 16 p. Доступно на: https://uroweb. org/wp-content/uploads/EAU-Guidelines-Urological-Infections-2016-1.pdf.
  17. Grabe M, Bjerklund-Johansen TE, Botto H, Wullt B, Çek M, Naber KG, Pickard RS, Tenke P, Wagenlehner F. Guidelines on Urological Infections [Internet]. European Association of Urology; 2012 [cited 2017 Nov 23]. 110 p. Доступно на: http://uroweb.org/wp-content/uploads/EAU-Guidelines-Urological-infections-2012.pdf.
  18. Grabe M, Bjerklund-Johansen TE, Botto H, Çek M, Naber KG, Pickard RS, Tenke P, Wagenlehner F, Wullt B. Guidelines on Urological Infections [Internet]. European Association of Urology; 2013 [cited 2017 Nov 23]. 106 p. Доступно на: http://uroweb.org/wp-content/ uploads/18_Urological-infections_LR.pdf.
  19. Гаджиева ЗК, Казилов ЮБ. Особенности подхода к профилактике рецидивирующей инфекции нижних мочевыводящих путей. Урология. 2016;(3 Прилож):65–76.
  20. Jepson RG, Williams G, Craig JC. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev. 2012;10:CD001321. doi: 10.1002/14651858.CD001321.pub5.
  21. Freire Gde C. Cranberries for preventing urinary tract infections. Sao Paulo Med J. 2013;131(5): 363. doi: 10.1590/1516-3180.20131315T1.
  22. Singh I, Gautam LK, Kaur IR. Effect of oral cranberry extract (standardized proanthocyanidin-A) in patients with recurrent UTI by pathogenic E. coli: a randomized placebo-controlled clinical research study. Int Urol Nephrol. 2016;48(9): 1379–86. doi: 10.1007/s11255-016-1342-8.
  23. Lüthje P, Brauner A. Novel strategies in the prevention and treatment of urinary tract infections. Pathogens. 2016;5(1). pii: E13. doi: 10.3390/pathogens5010013.
  24. McLellan LK, Hunstad DA. Urinary tract infection: pathogenesis and outlook. Trends Mol Med. 2016;22(11): 946–57. doi: 10.1016/j. molmed.2016.09.003.
  25. Carraro-Eduardo JC, Gava IA. Use of vaccines for prophylaxis of urinary tract infections. J Bras Nefrol. 2012;34(2): 178–83. doi: 10.1590/S0101-28002012000200011.
  26. Beerepoot MA, Geerlings SE, van Haarst EP, van Charante NM, ter Riet G. Nonantibiotic prophylaxis for recurrent urinary tract infections: a systematic review and meta-analysis of randomized controlled trials. J Urol. 2013;190(6): 1981–9. doi: 10.1016/j.juro.2013.04.142.
  27. Nagamatsu K, Hannan TJ, Guest RL, Kostakioti M, Hadjifrangiskou M, Binkley J, Dodson K, Raivio TL, Hultgren SJ. Dysregulation of Escherichia coli α-hemolysin expression alters the course of acute and persistent urinary tract infection. Proc Natl Acad Sci U S A. 2015;112(8):E871–80. doi: 10.1073/ pnas.1500374112.
  28. Ребров БА. Инфекции мочевой системы. В: Ребров БА, ред. Патология внутренних органов и беременность: учебное пособие. Донецьк: Видавник Заславський А.Ю.; 2010. с. 264–95.
  29. Zacchè MM, Giarenis I. Therapies in early development for the treatment of urinary tract inflammation. Expert Opin Investig Drugs. 2016;25(5): 531–40. doi: 10.1517/13543784.2016.1161024.
  30. Övünç Hacıhamdioğlu D, Altun D, Hacıhamdioğlu B, Çekmez F, Aydemir G, Kul M, Müftüoğlu T, Süleymanoğlu S, Karademir F. The association between serum 25-hydroxy vitamin d level and urine cathelicidin in children with a urinary tract infection. J Clin Res Pediatr Endocrinol. 2016;8(3): 325–9. doi: 10.4274/jcrpe.2563.
  31. Madersbacher H, van Ophoven A, van Kerrebroeck PE. GAG layer replenishment therapy for chronic forms of cystitis with intravesical glycosaminoglycans – a review. Neurourol Urodyn. 2013;32(1): 9–18. doi: 10.1002/nau.22256.
  32. Vahlensieck W, Perepanova T, Bjerklund Johansen TE, Tenke P, Naber KG, Wagenlehner FME. Management of uncomplicated recurrent urinary tract infections. European Urology Supplements. 2016;15(4): 95–101. doi: 10.1016/j. eursup.2016.04.007.
  33. Nicolle LE, Bradley S, Colgan R, Rice JC, Schaeffer A, Hooton TM; Infectious Diseases Society of America; American Society of Nephrology; American Geriatric Society. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis. 2005;40(5): 643–54. doi: 10.1086/427507.
  34. Parish A, Holliday K. Long-term care acquired urinary tract infections' antibiotic resistance patterns and empiric therapy: a pilot study. Geriatr Nurs. 2012;33(6): 473–8. doi: 10.1016/j. gerinurse.2012.05.003.
  35. Matulay JT, Mlynarczyk CM, Cooper KL. Curr Bladder Dysfunct Rep. 2016;11(1): 53–60. doi: 10.1007/s11884-016-0351-x.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2017 Rebrov B.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies